--- sp.seq_info content (copy to Claude) ---
ID   ASTX1_ASTEC             Reviewed;          51 AA.
AC   E8RMD3;
DE   RecName: Full=Astexin-1 {ECO:0000303|PubMed:22949633, ECO:0000303|PubMed:23601645, ECO:0000303|PubMed:23862624};
DE   AltName: Full=Class II lasso peptide {ECO:0000303|PubMed:22949633, ECO:0000303|PubMed:23601645, ECO:0000303|PubMed:23862624};
DE   AltName: Full=Ribosomally synthesized and post-translationally modified peptide {ECO:0000303|PubMed:22949633, ECO:0000303|PubMed:23862624};
DE            Short=RiPP {ECO:0000303|PubMed:23862624};
DE   Flags: Precursor;
GN   Name=AtxA1 {ECO:0000303|PubMed:22949633, ECO:0000303|PubMed:23862624};
GN   OrderedLocusNames=Astex_2228 {ECO:0000312|EMBL:ADU13884.1};
OS   Asticcacaulis excentricus (strain ATCC 15261 / DSM 4724 / KCTC 12464 /
OS   NCIMB 9791 / VKM B-1370 / CB 48).
OC   Bacteria; Pseudomonadati; Pseudomonadota; Alphaproteobacteria;
OC   Caulobacterales; Caulobacteraceae; Asticcacaulis.
OX   NCBI_TaxID=573065;
RN   [1] {ECO:0000312|Proteomes:UP000001492}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15261 / DSM 4724 / KCTC 12464 / NCIMB 9791 / VKM B-1370 /
RC   CB 48;
RG   US DOE Joint Genome Institute;
RA   Lucas S., Copeland A., Lapidus A., Cheng J.-F., Bruce D., Goodwin L.,
RA   Pitluck S., Teshima H., Davenport K., Detter J.C., Han C., Tapia R.,
RA   Land M., Hauser L., Jeffries C., Kyrpides N., Ivanova N., Ovchinnikova G.,
RA   Brun Y.V., Woyke T.;
RT   "Complete sequence of chromosome 1 of Asticcacaulis excentricus CB 48.";
RL   Submitted (DEC-2010) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   EXPRESSION IN E.COLI.
RX   PubMed=23862624; DOI=10.1021/ja4054256;
RA   Maksimov M.O., Link A.J.;
RT   "Discovery and characterization of an isopeptidase that linearizes lasso
RT   peptides.";
RL   J. Am. Chem. Soc. 135:12038-12047(2013).
RN   [3] {ECO:0000305, ECO:0007744|PDB:2LTI}
RP   STRUCTURE BY NMR OF 29-51, FUNCTION, CROSS-LINK, EXPRESSION IN E.COLI, AND
RP   MASS SPECTROMETRY.
RC   STRAIN=ATCC 15261 / DSM 4724 / KCTC 12464 / NCIMB 9791 / VKM B-1370 /
RC   CB 48;
RX   PubMed=22949633; DOI=10.1073/pnas.1208978109;
RA   Maksimov M.O., Pelczer I., Link A.J.;
RT   "Precursor-centric genome-mining approach for lasso peptide discovery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:15223-15228(2012).
RN   [4] {ECO:0000305, ECO:0007744|PDB:2M37}
RP   STRUCTURE BY NMR OF 29-47, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   CROSS-LINK, EXPRESSION IN E.COLI, AND MUTAGENESIS OF TYR-42; PHE-43 AND
RP   ARG-47.
RX   PubMed=23601645; DOI=10.1016/j.chembiol.2013.03.013;
RA   Zimmermann M., Hegemann J.D., Xie X., Marahiel M.A.;
RT   "The astexin-1 lasso peptides: biosynthesis, stability, and structural
RT   studies.";
RL   Chem. Biol. 20:558-569(2013).
RN   [5] {ECO:0007744|PDB:2N68}
RP   STRUCTURE BY NMR OF 29-51.
RX   PubMed=26492187; DOI=10.1021/acschembio.5b00745;
RA   Zong C., Maksimov M.O., Link A.J.;
RT   "Construction of lasso peptide fusion proteins.";
RL   ACS Chem. Biol. 11:61-68(2016).
CC   -!- FUNCTION: Shows weak antimicrobial activity against its phylogenetic
CC       relative Caulobacter crescentus. Does not show activity against other
CC       bacteria tested (E.coli, Vibrio sp, Burkhoderia thailandensis, and
CC       Salmonella newport). {ECO:0000269|PubMed:22949633}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Temperature dependence:
CC         Irreversibly unfolds upon heat treatment (PubMed:23601645). Between
CC         50 and 65 degrees Celsius, the protein shows an intermediate fold
CC         (PubMed:23601645). At more than 65 degrees Celsius, the protein is
CC         completely unfolded (PubMed:23601645). {ECO:0000269|PubMed:23601645};
CC   -!- DOMAIN: Is composed of a ring composed by 9 residues, a loop and a C-
CC       terminal tail (PubMed:23601645). The peptide is threaded when the C-
CC       terminal tail is inserted throught the isopeptide-bonded ring
CC       (Probable). {ECO:0000269|PubMed:23601645, ECO:0000305}.
CC   -!- PTM: This lasso peptide is probably hydrolyzed to a linear form by the
CC       isopeptidase AtxE1, in vivo. {ECO:0000269|PubMed:23862624}.
CC   -!- MASS SPECTROMETRY: Mass=2563.96; Method=MALDI; Note=when expressed in
CC       E.coli.; Evidence={ECO:0000269|PubMed:22949633};
DR   EMBL; CP002395; ADU13884.1; -; Genomic_DNA.
DR   RefSeq; WP_013479712.1; NC_014816.1.
DR   PDB; 2LTI; NMR; -; A=29-51.
DR   PDB; 2M37; NMR; -; A=29-47.
DR   PDB; 2N68; NMR; -; A=29-51.
DR   PDBsum; 2LTI; -.
DR   PDBsum; 2M37; -.
DR   PDBsum; 2N68; -.
DR   AlphaFoldDB; E8RMD3; -.
DR   BMRB; E8RMD3; -.
DR   SMR; E8RMD3; -.
DR   STRING; 573065.Astex_2228; -.
DR   KEGG; aex:Astex_2228; -.
DR   HOGENOM; CLU_3095092_0_0_5; -.
DR   EvolutionaryTrace; E8RMD3; -.
DR   Proteomes; UP000001492; Chromosome 1.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic; Antimicrobial; Isopeptide bond;
KW   Reference proteome.
FT   PROPEP          1..28
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000450588"
FT   PEPTIDE         29..51
FT                   /note="Astexin-1"
FT                   /evidence="ECO:0000305|PubMed:22949633,
FT                   ECO:0000305|PubMed:23601645"
FT                   /id="PRO_0000450589"
FT   SITE            42
FT                   /note="Important for stabilization of the lasso structure"
FT                   /evidence="ECO:0000305|PubMed:23601645"
FT   SITE            43
FT                   /note="Important for stabilization of the lasso structure"
FT                   /evidence="ECO:0000305|PubMed:23601645"
FT   CROSSLNK        29..37
FT                   /note="Isoaspartyl glycine isopeptide (Gly-Asp)"
FT                   /evidence="ECO:0000269|PubMed:22949633,
FT                   ECO:0000269|PubMed:23601645"
FT   MUTAGEN         42
FT                   /note="Y->A: Almost complete loss of Astexin-1 production.
FT                   Is unfolded."
FT                   /evidence="ECO:0000269|PubMed:23601645"
FT   MUTAGEN         42
FT                   /note="Y->W: No change in thermostability."
FT                   /evidence="ECO:0000269|PubMed:23601645"
FT   MUTAGEN         43
FT                   /note="F->A: Loss of Astexin-1 production. No change in
FT                   thermostability."
FT                   /evidence="ECO:0000269|PubMed:23601645"
FT   MUTAGEN         43
FT                   /note="F->W: Gain in thermostability."
FT                   /evidence="ECO:0000269|PubMed:23601645"
FT   MUTAGEN         47
FT                   /note="R->W: No change in thermostability."
FT                   /evidence="ECO:0000269|PubMed:23601645"
FT   STRAND          31..35
FT                   /evidence="ECO:0007829|PDB:2LTI"
FT   STRAND          38..40
FT                   /evidence="ECO:0007829|PDB:2M37"
FT   STRAND          42..46
FT                   /evidence="ECO:0007829|PDB:2LTI"
SQ   SEQUENCE   51 AA;  5514 MW;  111DA6B651CCCA3B CRC64;
//

--- End of sp.seq_info ---

--- species summary (copy to Claude) ---
Number  Rank    Taxon
1	6	Asticcacaulis.
1	5	Caulobacteraceae
1	4	Caulobacterales
1	3	Alphaproteobacteria
1	2	Pseudomonadota
1	1	Pseudomonadati
1	0	Bacteria
Total of 1 proteins found

--- End of species summary ---

--- Domain architectures (copy to Claude) ---
E8RMD3	ASTEXIN-1 {ECO:0000303|PUBMED:    138.9    1.7e-37   1   1.0   0.2
	E8RMD3                    	     1	    51	   138.8


--- End of Domain architectures ---

--- TED domain information (copy to Claude) ---
Protein_Accession	TED_Domains	Domain_Count	Domain_IDs	Domain_Ranges	Overlap_with_Pfam

--- End of TED domain information ---

--- Current DESC file (copy to Claude) ---
ID   ShortName
DE   Family description
AU   Bateman A;0000-0002-6982-4660
SE   ECOD:E8RMD3
GA   27.00 27.00;
TC   30.00 138.80;
NC   25.70 20.50;
BM   hmmbuild  -o /dev/null HMM SEED
SM   hmmsearch --cpu 8 -E 1000 -Z 90746521 HMM pfamseq
TP   Family

--- End of Current DESC file ---